Kunal Khanna

Active Investor

Founder & CEO at VIVALDIS HEALTH AND FOODS PRIVATE LIMITED

Pune, Maharashtra

Kunal Khanna, Founder & CEO at VIVALDIS HEALTH AND FOODS PRIVATE LIMITED is an active investor based in Pune, Maharashtra. This profile covers what Kunal Khanna backs, at which stage, and how founders can reach out in 2026.

Mr. Kunal Khanna is a Co-Founder and serves as Chief Executive Officer and Executive Director at Vivaldis Health and Foods. Mr. Khanna, Executive Director and Co-founder of Vivaldis, has done his Master's in Business Administration from one of the world's most renowned institutions, London Business School, where he was also awarded the prestigious Sumantra Ghoshal Scholarship. He has over 10 years of hands-on experience in setting up and creating hugely successful businesses within the Global Pharmaceutical and Banking Industry across continents. He started his career in 2003 with Citibank India. He then moved with Citibank to London to help build their UK Private Banking operations. In his next role, he is credited with starting the operations for Société Générale Bank in Pune. After his MBA in 2010 from London Business School, he moved to Dubai and joined GlaxoSmithKline, where he was responsible for Mergers and Acquisitions. Thereafter, he was the Director for Business Development for Indian pharmaceutical major Emcure, responsible for the Middle East and Africa markets.

Investor type: Angel
Stages: Early Stage Venture
Location: Pune, Maharashtra
Typical check: $500K
Past investments: 3

Notable investments

Emcure Pharmaceuticals LimitedUth HealthcareTribe (Hotels and Resorts)

How to reach Kunal Khanna

Angels and operators like Kunal Khanna reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

Who is Kunal Khanna?

Kunal Khanna is an active investor, Founder & CEO at VIVALDIS HEALTH AND FOODS PRIVATE LIMITED. Round Funded tracks their focus and activity alongside thousands of investors.